We do not display all the achieved goals on the graph, you can get detailed information about the achieved goals in the corresponding section on this page
| Stock ticker: | AZN |
| Name: | ASTRAZENECA PLC |
| Sector: | Healthcare |
| Investing Risk: | LOW |
| Forecast length: | 1 months, 25 days |
| Accuracy: | 52.24 % |
| Average profit per target: | 9.63 % |
| Signal Date | Signal Price | Date Reached | Price Reached | Profit | Direction |
|---|---|---|---|---|---|
| 2022-06-10 | 57.99 $ | 2024-05-09 | 76.05 $ | 31.15% | |
| 2023-08-01 | 68.5 $ | 2024-08-12 | 81.36 $ | 18.76% | |
| 2023-08-08 | 67.57 $ | 2024-08-12 | 81.36 $ | 20.4% | |
| 2023-08-15 | 67.08 $ | 2024-08-27 | 85.98 $ | 28.17% | |
| 2023-10-03 | 63.95 $ | 2024-08-15 | 83.7 $ | 30.9% | |
| 2023-10-10 | 65.63 $ | 2024-08-15 | 83.7 $ | 27.53% | |
| 2023-11-21 | 62.03 $ | 2024-04-25 | 73.52 $ | 18.52% | |
| 2023-12-05 | 61.77 $ | 2024-04-25 | 73.52 $ | 19.02% | |
| 2023-12-12 | 61.74 $ | 2024-05-01 | 74.87 $ | 21.26% | |
| 2023-12-19 | 63.6 $ | 2024-08-02 | 80.17 $ | 26.05% | |
| 2023-12-26 | 64.18 $ | 2024-04-25 | 73.52 $ | 14.56% | |
| 2024-01-02 | 66.01 $ | 2024-04-25 | 73.52 $ | 11.38% | |
| 2024-01-09 | 66.5 $ | 2024-05-21 | 77.59 $ | 16.67% | |
| 2024-01-16 | 64.92 $ | 2024-05-01 | 74.87 $ | 15.33% | |
| 2024-03-12 | 66.04 $ | 2024-04-25 | 73.52 $ | 11.32% | |
| 2024-03-19 | 64.54 $ | 2024-04-25 | 73.52 $ | 13.92% | |
| 2024-03-26 | 65 $ | 2024-04-25 | 73.52 $ | 13.12% | |
| 2024-04-02 | 65.65 $ | 2024-04-25 | 73.52 $ | 11.99% | |
| 2025-01-28 | 68.61 $ | 2025-03-05 | 77.96 $ | 13.63% | |
| 2025-02-04 | 67.99 $ | 2025-03-04 | 77.25 $ | 13.62% |
June 26, 2025AstraZeneca's New Phase I Study on AZD5492: What Investors Need to Know ~1 min.AstraZeneca PLC has recently announced positive results from a Phase I study on its new drug candidate, AZD5492....
March 20, 2025AstraZeneca AZN: Among the Best Diabetes Stocks to Buy According to Billionaires ~1 min.AstraZeneca PLC (AZN) has been recognized as one of the best diabetes stocks to buy by billionaires....
March 16, 2025AstraZeneca's Experimental Blood Pressure Drug Could Become a Blockbuster ~2 min.AstraZeneca PLC (NASDAQ:AZN) has recently developed an experimental drug for treating high blood pressure, which experts believe has a strong potential to become a blockbuster in the pharmaceutical market....
March 15, 2025AstraZeneca's Experimental Blood Pressure Drug Shows Promising Results, Outperforms Broader Market ~1 min.AstraZeneca PLC's recent experimental blood pressure drug has shown promising results, performing significantly better than the broader market....
March 14, 2025AstraZeneca's Imfinzi success a step towards revolutionizing cancer treatment ~2 min.AstraZeneca PLC (AZN) continues to make significant strides in the field of cancer treatment with its groundbreaking drug, Imfinzi....
March 5, 2025ASTRAZENECA PLC Stock Hits Price Target Forecast with 13.63% Profit ~1 min.On January 28, 2025, QuantWave issued a long signal for ASTRAZENECA PLC stock when it was trading at 68.61 $....
March 4, 2025ASTRAZENECA PLC Hits Price Target Forecast with 13.62% Profit: A Sign of QuantWave's Accuracy ~2 min.ASTRAZENECA PLC (AZN) recently reached the price target forecast set by QuantWave on March 4, 2025, resulting in a profit of 13.62% for investors who followed the long signal issued on February 4, 2025....
February 28, 2025AstraZeneca PLC AZN: A Global Pharmaceutical Giant with Promising Growth Potential ~2 min.AstraZeneca PLC (AZN) is a renowned multinational pharmaceutical company with a strong presence in the global market....
February 26, 2025AstraZeneca PLC's Groundbreaking Research Leads to Exciting Discoveries in the Field of Medicine ~2 min.AstraZeneca PLC, a leading pharmaceutical company, has made significant advancements in the field of medicine through its groundbreaking research....
February 24, 2025AstraZeneca PLC Announces Positive Results from Clinical Trial ~2 min.AstraZeneca PLC, a leading pharmaceutical company, announced today that its latest clinical trial for a new drug has yielded positive results....
